High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform

Annals of the New York Academy of Sciences

Volumn 1022, Issue , 2004, Pages 250-256

  Lilleberg, S L ^a   Durocher, J ^a   Sanders, C ^a   Walters, K ^a   Culver, K ^b  

^a TRANSGENOMIC INC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

APC; BRAF; Colorectal cancer (CRC); Denaturing high performance liquid chromatography (DHPLC); K RAS; Mutation; Plasma DNA; TP53

Indexed keywords

APC PROTEIN; B RAF KINASE; DNA; ISOPROTEIN; K RAS PROTEIN; PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ANALYTIC METHOD; CLINICAL ARTICLE; CODON; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA ISOLATION; FLUORESCENCE; GENE AMPLIFICATION; GENE MUTATION; GENE TARGETING; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; PATHOLOGY; PLASMA; SCORING SYSTEM; SOMATIC MUTATION; STATISTICAL SIGNIFICANCE; TECHNOLOGY;

TETRAGASTRIS BALSAMIFERA;

EID: 3242697688     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1318.039     Document Type: Conference Paper

References (6)

1. FEARON, E.R. & B. VOGELSTEIN. 1990. Cell 61: 759-767.
2. SMITH, G., F.A. CAREY, J. BEATTIE et al. 2002. Proc. Natl. Acad. Sci. USA 99: 9433-9438.
3. XIAO, W. & P.J. OEFNER. 2001. Hum. Mutation 17: 439-474.
4. LILLEBERG, S.L. 2003. Curr. Opin. Drug Discov. Devel. 6: 237-252.
5. SILVA, J.M., J. SILVA, A. SANCHEZ, et al. 2002. Clin. Cancer Res. 8: 3761-3766.
6. TABACK, B., Y. FUJIWARA, H.-J. WANG, et al. 2001. Cancer Res. 61: 5723-5726.